Non-invasive Ventilation and Dex in Critically Ill Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 7, 2022

Primary Completion Date

April 21, 2024

Study Completion Date

April 21, 2024

Conditions
Respiratory Insufficiency
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine is an α2-adrenergic agonist sedative commonly used in invasive mechanical ventilation that promotes patient wakefulness, has no effect on respiratory drive, has important analgesic properties, and when compared to γ-aminobutyric acid receptor agonists like benzodiazepines, reduces delirium.

OTHER

Placebo

Normal saline placebo will be given as continuous infusion.

Trial Locations (3)

Unknown

Monash Medical Centre - Monash Health, Melbourne

King Abdulaziz Medical City - Riyadh, Riyadh

L8N4A6

St. Joseph's Healthcare Hamilton, Hamilton

All Listed Sponsors
lead

St. Joseph's Healthcare Hamilton

OTHER